Douglas Macdonald - Publications

Affiliations: 
CHDI Management 
Area:
Huntington's disease, biomarkers, gene therapy, gene silencing, GPCRs, mGluRs, Substance P, molecular pharmacology, TRK receptor, peptide synthesis,

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2001 Macdonald D, Mierke DF, Li H, Pellegrini M, Sachais B, Krause JE, Leeman SE, Boyd ND. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex. Biochemistry. 40: 2530-9. PMID 11327875 DOI: 10.1021/Bi001880X  0.541
2001 Li H, Macdonald DM, Hronowski X, Costello CE, Leeman SE, Boyd ND. Further definition of the substance P (SP)/neurokinin-1 receptor complex. MET-174 is the site of photoinsertion p-benzoylphenylalanine4 SP. The Journal of Biological Chemistry. 276: 10589-93. PMID 11116140 DOI: 10.1074/Jbc.M007397200  0.514
1996 MacDonald D, Silberman SC, Lowe JA, Drozda SE, Leeman SE, Boyd ND. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist. Molecular Pharmacology. 49: 808-13. PMID 8622630  0.523
1993 Unson CG, Macdonald D, Merrifield RB. The role of histidine-1 in glucagon action. Archives of Biochemistry and Biophysics. 300: 747-50. PMID 8382034 DOI: 10.1006/abbi.1993.1103  0.509
1991 Unson CG, Macdonald D, Ray K, Durrah TL, Merrifield RB. Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding. The Journal of Biological Chemistry. 266: 2763-6. PMID 1847133  0.508
Show low-probability matches.